v3.26.1
Condensed Balance Sheets - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 1,228,879 $ 1,952,464
Accounts receivable, net 74,844 32,175
Prepaid expenses 297,760 222,156
Other current assets 119,843 77,564
Total current assets 1,721,326 2,284,359
Investments 4,826,329 1,326,329
Property, plant and equipment, net 20,766,082 20,880,849
Other assets 28,476 28,476
Total assets 27,342,213 24,520,013
Current liabilities:    
Accounts payable 11,785,980 13,143,394
Accrued liabilities and other current liabilities 1,125,639 1,110,104
Short-term debt, net 6,577,194 6,809,215
Deferred Revenue 470,000
Total current liabilities 19,958,813 21,062,713
Warrant liability 928,435
Contingent liability 692,531 692,531
Total liabilities 21,579,779 21,755,244
Commitments and contingencies (Note 12)
Stockholders’ equity:    
Common, $0.0001 par value; 250,000,000 shares authorized and 546,635 shares issued at December 31, 2025; 250,000,000 shares authorized and 1,122,351 shares issued at March 31, 2026 112 55
Additional paid-in capital 110,805,688 111,280,560
Accumulated deficit (105,043,366) (108,515,846)
Total stockholders’ equity 5,762,434 2,764,769
Total liabilities and stockholders’ equity $ 27,342,213 $ 24,520,013